Pathstone Family Office’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.18M | Hold |
2,205,377
| – | – | 0.02% | 371 |
|
|
2023
Q2 | $4.04M | Sell |
2,205,377
-5,000
| -0.2% | -$9.15K | 0.06% | 195 |
|
|
2023
Q1 | $4.38M | Sell |
2,210,377
-2,210,377
| -50% | -$4.38M | 0.07% | 163 |
|
|
2022
Q4 | $212 | Hold |
4,420,754
| – | – | ﹤0.01% | 1477 |
|
|
2022
Q3 | $8.4M | Buy |
4,420,754
+2,210,377
| +100% | +$4.2M | 0.08% | 153 |
|
|
2022
Q2 | $4.66M | Buy |
+2,210,377
| New | +$4.66M | 0.1% | 110 |
|